Axonics, Inc. Profile Avatar - Palmy Investing

Axonics, Inc.

Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and u…
Medical - Devices
US, Irvine [HQ]

Balance Sheet

8 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2016 2017 2018 2019 2020 2021 2022 2023
Assets
10.00 29.00 171.00 219.00 342.00 547.00 659.00 719.00
Current
8.00 26.00 165.00 211.00 327.00 321.00 465.00 491.00
Non Current
2.00 2.00 6.00 8.00 14.00 226.00 194.00 228.00
Liabilities
47.00 64.00 28.00 36.00 54.00 65.00 89.00 82.00
Current
1.00 2.00 5.00 12.00 45.00 26.00 65.00 45.00
Non Current
45.00 62.00 22.00 24.00 9.00 38.00 23.00 36.00
Equity
-49.00 -66.00 143.00 183.00 287.00 482.00 570.00 637.00
Stockholders' Equity
-49.00 -66.00 143.00 183.00 287.00 482.00 570.00 637.00
Retained Earnings
-49.00 -67.00 -99.00 -179.00 -234.00 -314.00 -374.00 -380.00
Common Stock
- - - - - - - - - - - - - - - -
Preferred Stock
- - - - - - - - - - - - - - - -
Profit
-17.00 -18.00 -32.00 -79.00 -54.00 -80.00 -59.00 -6.00
Dividends
- - - - - - - - - - - - - - - -
Minority Interest
13.00 31.00 - - - - - - - - - - - -
Other Stockholders' Equity
- - 1.00 243.00 363.00 522.00 803.00 969.00 1,033.00
Loss Other Compr. Income
- - - - - - - - - - -6.00 -25.00 -15.00
End of AXNX's Analysis
CIK: 1603756 CUSIP: 05465P101 ISIN: US05465P1012 LEI: - UEI: -
Secondary Listings
AXNX has no secondary listings inside our databases.